Tobi

Tobi is a brand name of tobramycin, approved by the FDA in the following formulation(s):

TOBI (tobramycin - solution; inhalation)

• 
  Manufacturer: NOVARTIS PHARMS
  
  Approval date: December 22, 1997
  
  Strength(s): 300MG/5ML ^[RLD]

Has a generic version of Tobi been approved?

No. There is currently no therapeutically equivalent version of Tobi available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tobi. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Aminoglycoside formulation for aerosolization
  Patent 5,508,269
  Issued: April 16, 1996
  Inventor(s): Smith; Arnold L. & Ramsey; Bonnie W. & Montgomery; Alan B.
  Assignee(s): Pathogenesis Corporation
  An aminoglycoside formulation for delivery by aerosolization. The concentrated aminoglycoside formulation containing an efficacious amount of aminoglycoside able to inhibit 95-100% of susceptible bacteria. Aminoglycoside formulated in 5 ml solution of a quarter normal saline having pH between 5.5 and 6.5. The method for treatment of endobronchial infections by a produced by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5 .mu., produced by a jet or ultrasonic nebulizer.
  
  Patent expiration dates:
  
  
  • October 19, 2014
    
    ✓ 
    Patent use: TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA
    ✓ 
    Drug product
  
  

See also...

• Tobi Solution Consumer Information (Wolters Kluwer)
• Tobi inhalation Consumer Information (Cerner Multum)
• Tobi Advanced Consumer Information (Micromedex)
• Tobi AHFS DI Monographs (ASHP)
• Tobramycin Consumer Information (Wolters Kluwer)
• Tobramycin Solution Consumer Information (Wolters Kluwer)
• Tobramycin inhalation Consumer Information (Cerner Multum)
• Tobramycin injection Consumer Information (Cerner Multum)
• Tobramycin Inhalation Advanced Consumer Information (Micromedex)
• Tobramycin Injection Advanced Consumer Information (Micromedex)
• Tobramycin Sulfate AHFS DI Monographs (ASHP)